The September 1, 2008, article by Goldstein et al, entitled “Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features” (J Clin Oncol 26:4063–4071, 2008), contained errors.
The Running Head was given as: “21-Gene Assay Compared With Adjuvant!”
While it should have been: “21-Gene Assay Compared With Clinicopathologic Features.”
In Figures 2, 3, 4(B & C), and 5(A), the term “Adjuvant!” was used, whereas it should have been “Integrator.”
The online version has been corrected in departure from the print.